Published 4 years ago

EU regulator backs dexamethasone as COVID-19 treatment

Summary by Reuters

Europe’s healthcare regulator has endorsed using dexamethasone to treat COVID-19 patients with breathing difficulties, paving the way for the steroid to become the region’s second approved treatment for the respiratory illness.

0 Articles

All

Left

Center

Right

Yahoo News

EU regulator backs dexamethasone as COVID-19 treatment

The European Medicines Agency (EMA) said on Friday the drug could be an option to treat adults and adolescents needing oxygen therapy or mechanical ventilation, after concluding its review of results from a trial by British scientists. The study, dubbed RECOVERY, by researchers at the University of

4 years ago·Los Angeles, United States

Read Full Article

Reuters

EU regulator backs dexamethasone as COVID-19 treatment

Europe's healthcare regulator has endorsed using dexamethasone to treat COVID-19 patients with breathing difficulties, paving the way for the steroid to become the region's second approved treatment for the respiratory illness.

4 years ago·United Kingdom

Read Full Article

Hindustan Times

EU regulator backs dexamethasone as Covid-19 treatment

4 years ago·New Delhi, India

Read Full Article

News24

EU regulator backs dexamethasone as Covid-19 treatment

Europe's healthcare regulator has endorsed using dexamethasone to treat Covid-19 patients with breathing difficulties, paving the way for the steroid to become the region's second approved treatment for the respiratory illness.

4 years ago·South Africa

Read Full Article

Financial Post

EU regulator backs dexamethasone as COVID-19 treatment

Europe’s healthcare regulator has endorsed using dexamethasone to treat COVID-19 patients with breathing difficulties, paving the way for the steroid to become…

4 years ago·Canada

Read Full Article

Medscape

EMA Backs Dexamethasone for Severe COVID-19 After Data Review

Dexamethasone can be considered a treatment option for adults and adolescents with SARS-CoV-2 infection who require supplemental oxygen therapy. International Approvals

4 years ago·United States

Read Full Article

Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/year

Ground News Article Assistant

Not enough coverage to generate an Article Assistant.